124 related articles for article (PubMed ID: 2907608)
1. Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors.
Connaughton S; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):379-82. PubMed ID: 2907608
[TBL] [Abstract][Full Text] [Related]
2. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
Oriowo MA; Hieble JP; Ruffolo RR
Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
[TBL] [Abstract][Full Text] [Related]
3. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078.
Ruffolo RR; Sulpizio AC; Nichols AJ; DeMarinis RM; Hieble JP
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):415-8. PubMed ID: 2893296
[TBL] [Abstract][Full Text] [Related]
5. No evidence for differences between pre- and postjunctional alpha 2-adrenoceptors in the periphery.
Connaughton S; Docherty JR
Br J Pharmacol; 1990 Jan; 99(1):97-102. PubMed ID: 1970496
[TBL] [Abstract][Full Text] [Related]
6. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
[TBL] [Abstract][Full Text] [Related]
7. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
Daly RN; Sulpizio AC; Levitt B; DeMarinis RM; Regan JW; Ruffolo RR; Hieble JP
J Pharmacol Exp Ther; 1988 Oct; 247(1):122-8. PubMed ID: 2902209
[TBL] [Abstract][Full Text] [Related]
8. An attempt at selective protection from phenoxybenzamine of postjunctional alpha-adrenoceptor subtypes mediating contractions to noradrenaline in the rabbit isolated saphenous vein.
Daly CJ; Dunn WR; McGrath JC; Wilson VG
Br J Pharmacol; 1988 Oct; 95(2):501-11. PubMed ID: 2906558
[TBL] [Abstract][Full Text] [Related]
9. Characterization of alpha-adrenoceptors mediating sympathetic vasoconstriction in rat autoperfused hindlimb: effects of SK&F 104078.
Medgett IC; Ruffolo RR
Eur J Pharmacol; 1987 Dec; 144(3):393-7. PubMed ID: 2894316
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
[TBL] [Abstract][Full Text] [Related]
11. Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity.
Hieble JP; DeMarinis RM; Fowler PJ; Matthews WD
J Pharmacol Exp Ther; 1986 Jan; 236(1):90-6. PubMed ID: 2867217
[TBL] [Abstract][Full Text] [Related]
12. An investigation of age-related changes in pre- and postjunctional alpha-adrenoceptors in human saphenous vein.
Hyland L; Docherty JR
Eur J Pharmacol; 1985 Aug; 114(3):361-4. PubMed ID: 2998813
[TBL] [Abstract][Full Text] [Related]
13. SK&F 104078, a post-junctionally selective alpha 2-adrenoceptor antagonist in the human saphenous vein in vitro.
Roberts SP; Kelly J; Cawthorne MA; Sennitt MV
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):327-32. PubMed ID: 1352382
[TBL] [Abstract][Full Text] [Related]
14. No evidence for differences between pre- and post-junctional alpha 2-adrenoceptors.
Docherty JR; Hyland L
Br J Pharmacol; 1985 Oct; 86(2):335-9. PubMed ID: 2864971
[TBL] [Abstract][Full Text] [Related]
15. Electrochemical and electrophysiological analysis of the effects of SK&F 104078 on prejunctional alpha 2-adrenoceptors.
Bao JX; Gonon F; Stjärne L
Eur J Pharmacol; 1991 Oct; 203(2):159-63. PubMed ID: 1686858
[TBL] [Abstract][Full Text] [Related]
16. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.
Alabaster VA; Keir RF; Peters CJ
Br J Pharmacol; 1986 Jul; 88(3):607-14. PubMed ID: 2874857
[TBL] [Abstract][Full Text] [Related]
17. Evidence for neuro-effector transmission through postjunctional alpha 2-adrenoceptors in human saphenous vein.
Docherty JR; Hyland L
Br J Pharmacol; 1985 Feb; 84(2):573-6. PubMed ID: 2983815
[TBL] [Abstract][Full Text] [Related]
18. Functional evidence for heterogeneity of peripheral prejunctional alpha 2-adrenoceptors.
Connaughton S; Docherty JR
Br J Pharmacol; 1990 Oct; 101(2):285-90. PubMed ID: 1979507
[TBL] [Abstract][Full Text] [Related]
19. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
20. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
